Telomir Pharmaceuticals, Inc. Common StockTELONASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
77.39%
↑ 234% above average
Average (14q)
-57.77%
Historical baseline
Range
High:77.39%
Low:-307.34%
Volatility
-665.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 77.39% |
| Q2 2025 | -131.74% |
| Q1 2025 | 24.70% |
| Q4 2024 | 51.63% |
| Q3 2024 | -307.34% |
| Q2 2024 | 23.05% |
| Q1 2024 | -77.64% |
| Q4 2023 | -13.05% |
| Q3 2023 | 33.10% |
| Q2 2023 | -195.34% |
| Q1 2023 | 0.85% |
| Q4 2022 | -108.61% |
| Q3 2022 | -233.26% |
| Q2 2022 | -10.35% |
| Q1 2022 | 0.00% |